US Broker Ratings

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Evaluating the Biotech’s Steady Trajectory

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company with a focus on novel treatments for rare diseases, is garnering attention from investors intrigued by its niche market focus and solid..

Inspire Medical Systems, Inc. (INSP): Growth Potential and Investor Outlook in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pioneer in medical technology dedicated to offering minimally invasive solutions for obstructive sleep apnea (OSA), stands at a pivotal juncture in the healthcare..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a Potential 43.7% Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, focuses on the development of innovative RNA-targeted therapeutics and genetic therapies aimed at treating rare diseases. With a..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a Potential 53.76% Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing investor attention with its impressive market cap of $13.08 billion and a promising pipeline of genetic..

Bausch + Lomb Corporation (BLCO): Investor Outlook with an 18.53% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $5.38..

Elanco Animal Health (ELAN) Stock Analysis: A Promising 23% Upside Fuels Investor Interest

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the animal health industry, presents a compelling case for investors with its strong market presence and promising growth potential. With..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Evaluating the 31.9% Revenue Growth and Its Implications for Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a key player in the biotechnology sector, has captured the attention of investors with its impressive 31.9% revenue growth. Based in Pittsburgh, Pennsylvania, Krystal Biotech..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unveiling a 39.69% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. As a leading..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling Growth Potential in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, stands out in the medical distribution industry with a robust market capitalization of $9.26 billion. As a key..

Teleflex Incorporated (TFX) Stock Analysis: Unlocking 11.81% Potential Upside in the Medical Device Sector

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents a promising investment opportunity with a potential upside of 11.81%, based on current..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Promising Upside Amidst Strong Buy Ratings

Investors eyeing the biotechnology sector may find Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) a compelling option, particularly given its potential upside of 57.20% as reflected in the current analyst ratings. As..

Repligen Corporation (RGEN) Stock Analysis: A Promising 34.85% Upside Potential in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializing in medical instruments and supplies, presents a compelling investment opportunity for those looking to capitalize on its robust..

BrightSpring Health Services, Inc. (BTSG): Analyzing a Strong Buy Rating with Robust Revenue Growth in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare sector, particularly within the health information services industry. With a significant market capitalization of $12.41 billion and a presence firmly..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Complex Landscape with Potential Amidst Volatility

Moderna, Inc. (NASDAQ: MRNA) stands as a prominent player in the biotechnology sector, with a market capitalization of $19.8 billion. Known for its pioneering work in messenger RNA (mRNA) medicines,..

Molina Healthcare (MOH) Stock Analysis: Navigating a 52-Week High Amidst Analyst Consensus

Molina Healthcare Inc (NYSE: MOH), a leading player in the healthcare plans industry, is a company that draws much attention due to its strategic focus on serving low-income families through..

Oscar Health, Inc. (OSCR)

⚠️ No article content returned.

..

Insulet Corporation (PODD): Investor Outlook Highlights 61.95% Potential Upside Amid Strong Buy Ratings

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector focusing on medical devices, has recently caught the attention of investors due to its promising growth metrics and robust..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A 23% Upside Potential in the Booming Biotech Sector

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, showcasing its prowess in developing transformative medicines for serious diseases. With a market capitalization of $112.92..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with a 20% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is capturing investor attention with its innovative biotechnology platform and promising growth trajectory. As a major player in the healthcare sector, Halozyme is leveraging its..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds